Close Menu

Missing From Trials

African-American patients are missing out on cancer drug clinical trial opportunities, Stat News and ProPublica report. Their analysis of US Food and Drug Administration data found that for most trials for cancer drugs approved since 2015, fewer than 5 percent of the patients who participated were African American, even as African Americans make up 13.4 percent of the US population.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.